Vial Closure for Cold-Chain Drugs: How Seals Behave Through Freeze and Thaw

A vial closure for a cold-chain drug has to hold the sterile barrier through refrigeration, freezing, transport shock, and thaw, and a crimped aluminium seal is well suited to this because it seals mechanically, by holding the rubber stopper compressed against the glass, with no adhesive that could fail at low temperature. The compression that seals the vial does not depend on glue or on a chemical bond; it depends on the elastic stopper being held under load by the crimp, and that mechanical relationship is stable across the cold-chain temperature range. This is why crimped aluminium seals are the standard closure on cold-stored vaccines and biologics, where the product may sit at 2 to 8 degrees Celsius, be frozen much colder, and then be thawed before use.

This guide explains what the cold chain demands of a closure, why a mechanical crimp suits it, what freeze-thaw stress does, and how integrity is confirmed.

Key takeaways

A cold-chain closure must keep the sterile barrier intact through refrigeration, freezing, transport, and thaw.
A crimped aluminium seal seals mechanically, holding the stopper compressed against the glass, with no adhesive that could fail cold.
Materials matter: aluminium and an elastomeric stopper stay dimensionally stable and elastic enough across the cold-chain range.
Freeze-thaw stresses the glass-stopper-seal interface, so a consistent, correctly applied crimp is important for retaining integrity.
Cold-chain products are a core use for these seals, especially vaccines and biologics.
Integrity through the cold chain is confirmed by container closure integrity testing within the USP <1207> framework.

What the cold chain demands of a closure

The cold chain demands a closure that keeps the vial sealed not just at room temperature but through low and sub-zero storage, temperature cycling, and the mechanical shock of transport. A cold-chain product is refrigerated, sometimes deep-frozen, moved through distribution, and thawed, and the closure has to keep its integrity at every step.

That is a harder job than sealing a vial that stays at ambient. The closure sees thermal contraction and expansion of the glass, the stopper, and the seal; it sees vibration and handling; and for frozen products it sees the volume change of the contents freezing. Throughout, the container closure integrity must hold, because a cold-chain product, typically a sterile injectable, cannot be re-sterilised if the barrier is lost. So the closure is chosen for stability across temperature, not just for a good seal at the point of filling.

Why a mechanical aluminium crimp suits cold chain

A crimped aluminium seal suits the cold chain because it seals by mechanical compression rather than by any adhesive, so there is no glue line to embrittle, shrink, or debond when the vial is cold. The seal works by the same principle at every temperature: the crimp holds the elastic stopper pressed against the glass, and that compression closes the leak path.

No adhesive to fail. The barrier is compression, not a bond, so there is nothing to lose strength or crack at low temperature.
Aluminium stays stable. The seal metal keeps its shape and holds the stopper down across the cold-chain range.
The elastomer stays resilient. A suitable rubber stopper remains elastic enough at cold-chain temperatures to keep filling the interface under the crimp’s load; it is chosen as an elastomeric closure matched to the seal.
Consistent crimp, consistent hold. Because the seal is applied to controlled dimensions, the compression is even, so integrity is retained uniformly across a batch even as temperature changes.

This mechanical, adhesive-free design is a large part of why crimped aluminium seals are the default for cold-stored injectables. The crimp mechanism itself is covered in vial crimping explained.

What freeze and thaw do to the closure

Freeze-thaw cycling stresses the interface between the glass, the stopper, and the seal, because the components contract and expand at different rates and the contents may change volume, so the closure has to accommodate that movement without opening a leak path. This is where a well-matched, correctly crimped closure earns its place.

Thermal contraction and expansion: glass, rubber, and aluminium respond differently to temperature, straining the interface as the vial cools and warms.
Content volume change: a product that freezes expands, which can push on the stopper from inside.
Repeated cycling: more than one freeze-thaw event accumulates stress, so integrity has to survive cycling, not just a single excursion.
Handling at temperature: cold components can be more brittle, so gentle handling and a robust crimp matter.

The mitigation is a closure whose components are matched in size and finish, whose stopper stays resilient at temperature, and whose crimp is even and correct, so the compression that seals the vial is maintained through the movement. This is one reason dimensional consistency in the seal, discussed in pairing the rubber stopper and aluminium seal, matters more, not less, for cold-chain products.

Confirming integrity through the cold chain

Integrity through the cold chain is confirmed the same way as any closure integrity claim, by container closure integrity testing within the USP <1207> framework, but with the testing designed to cover the cold-chain conditions the product will actually see. It is not enough to show a good seal at ambient; the package has to be shown to hold after the relevant thermal and transport stresses.

Test after stress: integrity is evaluated after storage, freeze-thaw cycling, or transport simulation representative of the product’s cold chain.
Deterministic methods preferred: quantitative CCIT methods (such as vacuum or pressure decay, or helium leak testing) give reproducible results, as framed by USP <1207>.
Cover the worst case: testing targets the leak size and the conditions that matter for the product’s sterility over its shelf life.

So the cold-chain closure claim is a tested claim: the crimped seal is chosen for its mechanical stability, and the package is then demonstrated to hold integrity across the conditions it will meet. The method landscape is on the container closure integrity testing page.

How this works in practice at Autofits

Autofits supplies the crimped aluminium seals used on cold-stored injectables, built for the mechanical, adhesive-free sealing the cold chain needs. The FlipTop Optima flip-off seals are made from AA8011 aluminium with an epoxy lacquer and a polypropylene button, and they seal purely by holding the stopper compressed against the glass, with no adhesive in the closure. They are produced to drawing-controlled dimensions and checked by 100% high-speed camera inspection, so the crimp is even and integrity is retained uniformly across a batch, which matters under freeze-thaw stress. For aseptic cold-chain filling, seals are available Ready-to-Use, assembled in an ISO Class 8 cleanroom, washed to control particles, double-bagged, and sterilised (gamma or ETO). This makes them a fit for vaccine and biologic vials, where cold storage and integrity are both critical. Production runs under an ISO 15378:2017 quality system in a 75,000 sq ft Nashik facility.

Frequently asked questions

Why is a crimped aluminium seal good for cold-chain drugs?

A crimped aluminium seal is good for cold-chain drugs because it seals mechanically, by holding the rubber stopper compressed against the glass, with no adhesive. There is no glue line to embrittle or debond when the vial is cold, so the sealing principle is stable across the cold-chain temperature range. The aluminium keeps its shape and the elastomeric stopper stays resilient, so the compression that seals the vial is maintained.

What happens to a vial closure when the product freezes and thaws?

When a product freezes and thaws, the glass, stopper, and seal contract and expand at different rates, and a product that freezes expands in volume, so the glass-stopper-seal interface is stressed. A well-matched closure with a correct, even crimp accommodates that movement without opening a leak path. Repeated cycling accumulates stress, so integrity has to survive cycling, which is why component matching and crimp consistency matter.

Are flip-off seals used on vaccines?

Yes. Flip-off aluminium-plastic seals are the standard closure on many vaccine vials, including cold-stored ones. They seal mechanically without adhesive, provide tool-free access and colour-coding, and can be supplied ready-to-use for aseptic filling. Their stability through refrigeration, freezing, and thaw is a key reason they are used across the vaccine cold chain.

How is cold-chain closure integrity tested?

Cold-chain closure integrity is tested by container closure integrity testing (CCIT) within the USP <1207> framework, with the testing designed to cover the cold-chain conditions the product will see. Integrity is evaluated after representative storage, freeze-thaw cycling, or transport simulation, typically using deterministic methods such as vacuum or pressure decay or helium leak testing, targeting the leak size that matters for sterility.

Does a mechanical crimp seal better than an adhesive at low temperature?

For vial closures, a mechanical crimp is preferred at low temperature because it does not rely on an adhesive that could shrink, embrittle, or debond when cold. The crimp holds the elastic stopper compressed against the glass, and that compression closes the leak path by the same mechanism at every temperature. There is no bond line to fail, which is why crimped aluminium seals are the default for cold-stored injectables.

Sources

USP-NF: General Chapter <1207>, Package Integrity Evaluation, Sterile Products (https://www.usp.org/)
WHO: Guidelines on the international packaging and shipping of vaccines and cold-chain management (https://www.who.int/)
ISO: ISO 8362-6:2010, Injection containers and accessories, Part 6: Caps made of aluminium-plastics combinations for injection vials (https://www.iso.org/standard/52806.html)

*Last updated: 2026-07-06. This article is general technical information, not regulatory or compliance advice; confirm current standard editions and requirements with the issuing bodies.*